Healthcare ❯Pharmaceutical Industry

Drug Development

Clinical Trials Research and Development Antibiotics Covid-19 Vaccines Regulatory Compliance Cancer Treatments Efficacy Studies Weight Loss Medications FDA Approval Cancer Drugs Monoclonal Antibodies Research Funding ALS Treatment Antiviral Drugs Regulatory Approval

Bristol Myers Squibb Predicts 2025 Revenue Decline, Expands Cost-Cutting Measures

The pharmaceutical company forecasts lower-than-expected earnings and revenue as it faces generic competition for key cancer drugs.

GLP-1 Drugs Revolutionize Prescriptions and Broader Health Applications

AstraZeneca's China Executive Detained Amid Drug Import Investigation

AstraZeneca's China President Under Investigation by Authorities

Experts Urge Action Amid Rising Antibiotic Resistance Crisis

Pfizer Withdraws Sickle Cell Drug Oxbryta Over Safety Concerns

ALS Drug Relyvrio Fails Key Clinical Trial, May Be Pulled from Market